clarithromycin has been researched along with clofazimine in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 23 (32.86) | 18.2507 |
2000's | 24 (34.29) | 29.6817 |
2010's | 19 (27.14) | 24.3611 |
2020's | 4 (5.71) | 2.80 |
Authors | Studies |
---|---|
Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Cynamon, MH; DeStefano, MS; Klemens, SP | 1 |
Cynamon, MH; Klemens, SP; Swenson, CE | 1 |
De Gregoris, P; Fattorini, L; Hu, CQ; Iona, E; Mascellino, MT; Orefici, G; Santoro, C | 1 |
Michałowska-Mitczuk, D | 1 |
Dekio, S; Hidaka, T; Kawahara, S; Saito, H; Sato, K; Tomioka, H | 1 |
Chauvin, JP; Dautzenberg, B; Durant, J; Legrand, MF; Meyohas, MC; Reynes, J; Saint-Marc, T; Truffot, C | 1 |
Marneff, E; Saint-Marc, T; Touraine, JL | 1 |
Fanning, MM; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Tsoukas, CM; Walmsley, SL; Zarowny, DP | 1 |
Coker, RJ; Fisher, M; Tomlinson, DR | 1 |
Benson, CA; Chaisson, RE; Craft, JC; Fessel, WJ; Keiser, P; Lahart, C; Meek, K; Pierce, M; Ruskin, J; Siepman, N | 1 |
Beuscart, C; Brel, F; Dautzenberg, B; Doco-Lecompte, T; Grosset, J; May, T; Perronne, C; Saint-Marc, T; Vincent, V | 1 |
Igual, J; Roussel, G | 1 |
Horgen, L; Legrand, E; Rastogi, N | 1 |
Horgen, L; Jerome, A; Rastogi, N | 1 |
Dubé, MP; Havlir, DV; Kemper, CA; Leedom, JM; McCutchan, JA; Sattler, FR; See, D; Tilles, JG; Torriani, FJ | 1 |
Burguière, AM; Eliaszewicz, M; Flahault, A; Fournier, S; Treilhou, MP; Vincent, V | 1 |
Chesnut, J; Child, CC; Clotfelter, J; Cohn, DL; El-Sadr, W; Fisher, EJ; Franchino, B; Gibert, CL; Hafner, R; Heifets, L; Hodges, JS; Horsburgh, CR; Korvick, J; Munroe, D; Peng, GT; Ropka, M | 1 |
Khorasheh, S; Lemieux, C; Raboud, JM; Salit, I; Shafran, SD; Singer, J; Thorne, A; Tsoukas, CM; Wu, AW | 1 |
Chen, SC; Furber, H; Hughes, MS; James, G; Love, DN; Lucas, A; Lucas, J; Malik, R; Martin, P; Mitchell, DH | 1 |
Kashiwabara, Y; Matsuoka, M; Namisato, M | 1 |
Cheng, B | 1 |
Prescott, LM | 1 |
Currier, J | 1 |
Hermon-Taylor, J | 2 |
Canfield, PJ; Chen, SC; Hughes, MS; James, G; Love, DN; Malik, R; Martin, P; Mitchell, DH; Wigney, DI | 1 |
Borody, TJ; Leis, S; Surace, R; Warren, EF | 1 |
Duangdeeden, I; Kullavanijaya, P; Rattana-Apiromyakij, N; Sirimachand, S; Sukonthapirom-Napattalung, P | 1 |
Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW | 1 |
Gidoh, M; Matsuoka, M; Yamazaki, T | 1 |
Greene, CE; Latimer, KS; Sanchez, S; Sessions, JK; Sieber-Ruckstuhl, NS | 1 |
Bilkey, S; Borody, TJ; Leis, S; Pang, G; Tye, S; Wettstein, AR | 1 |
Connell, W; Crotty, B; Ee, H; Florin, T; Gibson, P; Hetzel, D; Merrett, M; Mitchell, B; Pavli, P; Radford-Smith, G; Read, R; Selby, W | 1 |
Colombel, JF; Neut, C; Peyrin-Biroulet, L | 1 |
Kuenstner, JT | 1 |
Barash, DP; Lipton, JE | 1 |
Biesecker, J; Gitlin, L | 1 |
Chamberlin, W | 1 |
Behr, MA; Hanley, J | 1 |
Agnihotri, SP; Gupta, P; Gupta, S; Jain, NK; Sharma, KK | 1 |
Alffenaar, JW; Bolhuis, MS; Kosterink, JG; Uges, DR; van Altena, R; van der Werf, TS | 1 |
Fu, L; Li, P; Liang, BW; Lu, Y; Wang, B; Zhao, WJ; Zheng, MQ | 1 |
Hassan, G; Kant, S; Parengal, J; Saheer, S | 1 |
Uthman, MM; Uthman, OA; Yahaya, I | 1 |
Adamson, J; Converse, PJ; Grosset, JH; Kishi, Y; Li, SY; Nuermberger, EL; Tyagi, S; Xing, Y | 1 |
Andries, K; Arnett, KA; Creissen, E; Henao-Tamayo, M; Lenaerts, AJ; Massoudi, L; Obregón-Henao, A; Ordway, DJ | 1 |
de Jong, A; Ferro, BE; Meletiadis, J; Mouton, JW; van Ingen, J; van Soolingen, D; Wattenberg, M | 1 |
Achar, J; Bobokhojaev, OI; du Cros, P; Dusmatova, Z; Quinnell, S; Seddon, JA; Swaminathan, A | 1 |
Chande, N; MacDonald, JK; Parker, CE; Patton, PH | 1 |
Brouqui, P; Drancourt, M; Quenard, F | 1 |
Chen, HC; Huang, CC; Huang, WC; Wu, MF | 1 |
Jo, KW; Nam, GB; Shim, TS; Yoon, HY | 1 |
Zheng, S | 1 |
Ishii, N; Richardson, M; Yotsu, RR | 1 |
Bertani, L; Blandizzi, C; Bodini, G; Buda, A; Ceccarelli, L; Costa, F; De Bortoli, N; Facchin, S; Lorenzon, G; Marabotto, E; Marchi, S; Savarino, E; Savarino, V; Zingone, F | 1 |
Almeida, DV; Converse, PJ; Nuermberger, EL; Tyagi, S; Xu, J | 1 |
Jevert-Eichorn, S; Radigan, A | 1 |
Chen, J; Chen, X; Hua, W; Lin, S; Liu, H; Shao, L; Wang, S; Zhang, W; Zhang, Y | 1 |
Almond, LM; Beringer, PM; Chung, PS; Hong, E; Rao, AP | 1 |
Ammerman, NC; Bax, HI; de Steenwinkel, JEM; de Vogel, CP; Mudde, SE; Schildkraut, JA; van Ingen, J | 1 |
Çavuşoğlu, C; Gazi, H; Özkütük, N; Sürücüoğlu, S | 1 |
7 review(s) available for clarithromycin and clofazimine
Article | Year |
---|---|
[Patients with chronic sputum positive tuberculosis-a therapeutic problem].
Topics: Amikacin; Amoxicillin; Antitubercular Agents; Chronic Disease; Clarithromycin; Clofazimine; Humans; Rifabutin; Sputum; Tuberculosis, Pulmonary | 1995 |
Antimycobacterial therapy in Crohn's disease: game over?
Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Humans; Mycobacterium avium; Mycobacterium Infections; Rifabutin | 2007 |
Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Child; Clarithromycin; Clofazimine; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Randomized Controlled Trials as Topic; Rifabutin | 2013 |
Anti-tuberculous therapy for maintenance of remission in Crohn's disease.
Topics: Antitubercular Agents; Clarithromycin; Clofazimine; Crohn Disease; Ethambutol; Glucocorticoids; Humans; Maintenance Chemotherapy; Methylprednisolone; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Rifabutin; Rifampin; Secondary Prevention | 2016 |
Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB).
Topics: Antitubercular Agents; Clarithromycin; Clofazimine; Drug Resistance, Multiple, Bacterial; Drug Synergism; Extensively Drug-Resistant Tuberculosis; Humans; Minocycline; Mycobacterium tuberculosis; Phenothiazines; Sulfonamides | 2017 |
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).
Topics: Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Clofazimine; Drug Therapy, Combination; Humans; Mycobacterium ulcerans; Observational Studies as Topic; Randomized Controlled Trials as Topic; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn's disease: pharmacological and clinical implications.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Combinations; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Remission Induction; Rifabutin | 2019 |
13 trial(s) available for clarithromycin and clofazimine
Article | Year |
---|---|
New antibiotics look good against M. avium.
Topics: Acquired Immunodeficiency Syndrome; Azithromycin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Erythromycin; Humans; Mycobacterium avium-intracellulare Infection | 1992 |
[Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection].
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Child; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fluoroquinolones; Hearing Disorders; Humans; Liver Function Tests; Male; Middle Aged; Minocycline; Mycobacterium avium-intracellulare Infection; Recurrence; Treatment Outcome | 1994 |
[Mycobacterium avium intracellulare infections. Treatment with a clarithromycin-clofazimine combination. 18 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Chemical and Drug Induced Liver Injury; Clarithromycin; Clofazimine; Drug Therapy, Combination; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection | 1993 |
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Survival Analysis; Treatment Outcome; Uveitis | 1996 |
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium-intracellulare Infection | 1997 |
Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida.
Topics: Adult; AIDS-Related Opportunistic Infections; Bacteremia; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Mycobacterium avium-intracellulare Infection; Prospective Studies; Recurrence; Rifabutin | 1997 |
Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections à Mycobactéries.
Topics: Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Seronegativity; Humans; Male; Middle Aged; Minocycline; Mycobacterium avium-intracellulare Infection; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 1999 |
Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients.
Topics: Aged; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents, Non-Steroidal; Bacteremia; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Survival Analysis | 1999 |
A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Resear
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Clofazimine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Patient Compliance; Prospective Studies; Rifabutin; Survivors; Treatment Outcome | 1999 |
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Bacteremia; Canada; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Health Status; Humans; Mycobacterium avium-intracellulare Infection; Outcome and Process Assessment, Health Care; Rifabutin; Rifampin; Treatment Outcome | 2000 |
Anti-mycobacterial therapy in Crohn's disease heals mucosa with longitudinal scars.
Topics: Adolescent; Adult; Anti-Infective Agents; Clarithromycin; Clofazimine; Crohn Disease; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Mycobacterium avium; Retrospective Studies; Rifabutin; Treatment Outcome | 2007 |
Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Mycobacterium avium; Mycobacterium Infections; Patient Compliance; Prednisolone; Rifabutin; Treatment Failure | 2007 |
50 other study(ies) available for clarithromycin and clofazimine
Article | Year |
---|---|
Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.
Topics: 3T3 Cells; Adrenergic Uptake Inhibitors; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport, Active; Cell Line; Cell Separation; Cell Survival; Flow Cytometry; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Mice; Protein Binding; Reserpine; Spectrometry, Fluorescence; Substrate Specificity; Time Factors | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice.
Topics: Amikacin; Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred C57BL; Mycobacterium avium; Mycobacterium avium Complex; Quinolones; Rifabutin; Rifampin; Rifamycins; Time Factors; Tuberculosis | 1992 |
TLC G-65 in combination with other agents in the therapy of Mycobacterium avium infection in beige mice.
Topics: Amikacin; Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Culture Media; Drug Therapy, Combination; Erythromycin; Ethambutol; Gentamicins; Liposomes; Mice; Mice, Inbred C57BL; Mycobacterium avium; Rifampin; Tuberculosis | 1992 |
In vitro activity of clarithromycin alone or in combination with other antimicrobial agents against Mycobacterium avium-intracellulare. Complex strains isolated from AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Radiometry | 1991 |
Therapeutic effect of KRM-1648 with various antimicrobials against Mycobacterium avium complex infection in mice.
Topics: Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Drug Synergism; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolones; Rifamycins; Streptomycin | 1995 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1996 |
Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium.
Topics: Amikacin; Anti-Bacterial Agents; Bacteriological Techniques; Clarithromycin; Clofazimine; Colony Count, Microbial; Fluoroquinolones; Humans; Mycobacterium avium Complex; Quinolones; Rifampin; Serum Bactericidal Test | 1997 |
Pulsed-exposure and postantibiotic leukocyte enhancement effects of amikacin, clarithromycin, clofazimine, and rifampin against intracellular Mycobacterium avium.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Humans; Leukocytes; Macrophages; Mycobacterium avium; Phagocytosis; Rifampin | 1998 |
Mycobacterium genavense infection in two aged ferrets with conjunctival lesions.
Topics: Animals; Clarithromycin; Clofazimine; Conjunctivitis, Bacterial; Diagnosis, Differential; DNA Primers; Drug Therapy, Combination; Fatal Outcome; Female; Ferrets; Male; Mycobacterium; Mycobacterium Infections; Polymerase Chain Reaction; Rifampin; RNA, Bacterial | 2000 |
A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Colony Count, Microbial; Dapsone; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Leprostatic Agents; Leprosy; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mycobacterium leprae; Ofloxacin; Rifampin | 2000 |
Advances in prevention and treatment of MAC.
Topics: AIDS-Related Opportunistic Infections; Azithromycin; CD4 Lymphocyte Count; Clarithromycin; Clinical Trials as Topic; Clofazimine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin | 1995 |
Macrolides, azalides, and streptogrammins.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteremia; Bacterial Infections; Clarithromycin; Clofazimine; Cryptosporidiosis; Drug Therapy, Combination; Duodenal Ulcer; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium-intracellulare Infection; Pneumonia; Smoking; Virginiamycin | 1996 |
Progress report: prophylaxis and therapy for MAC.
Topics: Acquired Immunodeficiency Syndrome; Antitubercular Agents; Azithromycin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin | 1996 |
Pot shots.
Topics: Acetylcysteine; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Antitubercular Agents; Antiviral Agents; Cattle; CD4 Lymphocyte Count; China; Clarithromycin; Clinical Trials as Topic; Clofazimine; Cryptosporidiosis; Drug Combinations; Ethambutol; Expectorants; Glutathione; Hepatitis B; Humans; Immunoglobulins; Interferon-alpha; Italy; Leprostatic Agents; Mycobacterium avium-intracellulare Infection; Philippines; Protease Inhibitors; Survival Rate; Taiwan; Thymosin; Zidovudine | 1996 |
MAC management.
Topics: Acquired Immunodeficiency Syndrome; Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Interactions; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium avium-intracellulare Infection; Rifabutin; Rifampin; Tuberculin Test; Zidovudine | 1996 |
Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease.
Topics: Animals; Animals, Domestic; Cattle; Clarithromycin; Clofazimine; Crohn Disease; Disease Reservoirs; Drug Therapy, Combination; Humans; Intestines; Milk; Mycobacterium avium subsp. paratuberculosis; Rifabutin; Sheep | 2001 |
Feline leprosy: two different clinical syndromes.
Topics: Animals; Cat Diseases; Cats; Clarithromycin; Clofazimine; Female; Leprostatic Agents; Leprosy, Lepromatous; Male; Mycobacterium; Polymerase Chain Reaction; Rifampin; RNA, Ribosomal, 16S | 2002 |
Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?
Topics: Adolescent; Adult; Clarithromycin; Clofazimine; Colonoscopy; Crohn Disease; Drug Therapy, Combination; Female; Humans; Male; Mycobacterium avium subsp. paratuberculosis; Mycobacterium Infections; Pilot Projects; Prospective Studies; Rifabutin; Severity of Illness Index; Treatment Outcome | 2002 |
Treatment with drugs active against Mycobacterium avium subspecies paratuberculosis can heal Crohn's disease: more evidence for a neglected public health tragedy.
Topics: Clarithromycin; Clofazimine; Crohn Disease; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Rifabutin; Vaccines, DNA | 2002 |
Disseminated Mycobacterium chelonae cutaneous infection: recalcitrant to combined antibiotic therapy.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Cryotherapy; Drug Resistance; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Skin Diseases, Bacterial | 2003 |
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin | 2005 |
[Basic evaluation for new antimicrobial susceptibility testing of Mycobacterium leprae by bioluminescence assay (ATP method)].
Topics: Animals; Clarithromycin; Clofazimine; Drug Resistance, Bacterial; Leprostatic Agents; Leprosy; Luciferases; Luminescent Agents; Mice; Mice, Nude; Microbial Sensitivity Tests; Mycobacterium leprae; Ofloxacin; Rifampin | 2006 |
Long-term cure of disseminated Mycobacterium avium infection in a cat.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clarithromycin; Clofazimine; Diagnosis, Differential; Doxycycline; Male; Mycobacterium avium; Tuberculosis | 2007 |
The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study.
Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Rifabutin | 2007 |
Flawed Australian CD study does not end MAP controversy.
Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Rifabutin | 2007 |
Australian Crohn's antibiotic study opens new horizons.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Infliximab; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Remission Induction; Reproducibility of Results; Rifabutin; Treatment Outcome | 2007 |
Importance of the Australian Crohn's disease antibiotic study.
Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Data Interpretation, Statistical; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Rifabutin; Treatment Outcome | 2007 |
Antimycobacterial therapy for Crohn's disease: a reanalysis.
Topics: Adrenal Cortex Hormones; Antitubercular Agents; Clarithromycin; Clinical Trials as Topic; Clofazimine; Crohn Disease; Humans; Rifabutin | 2008 |
Extensively drug resistance (XDR) tb is not always fatal.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Aza Compounds; Capreomycin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; India; Injections; Male; Moxifloxacin; Quinolines; Sputum; Treatment Outcome | 2009 |
Clarithromycin significantly increases linezolid serum concentrations.
Topics: Acetamides; Adult; Chromatography, Liquid; Clarithromycin; Clofazimine; Cycloserine; Drug Interactions; Humans; Linezolid; Male; Oxazolidinones; Tandem Mass Spectrometry; Tuberculosis, Pulmonary | 2010 |
[A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis].
Topics: Animals; Antitubercular Agents; Clarithromycin; Clofazimine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant | 2010 |
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2012 |
Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease.
Topics: Animals; Buruli Ulcer; Clarithromycin; Clofazimine; Colony Count, Microbial; Drug Evaluation, Preclinical; Drug Therapy, Combination; Foot; Macrolides; Mice; Microbial Sensitivity Tests; Rifampin; Streptomycin; Survival Analysis; Time Factors; Treatment Outcome | 2015 |
Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Diarylquinolines; Granulocyte-Macrophage Colony-Stimulating Factor; Mice; Mice, Knockout; Mice, SCID; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections | 2015 |
Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Monte Carlo Method; Mutation; Mycobacterium avium; Nontuberculous Mycobacteria | 2016 |
Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Child; Child, Preschool; Clarithromycin; Clofazimine; Drug Combinations; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Linezolid; Male; Retrospective Studies; Sputum; Tajikistan; Treatment Outcome | 2016 |
In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Cycloserine; Drug Synergism; Fluoroquinolones; Gentamicins; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum; Streptomycin | 2018 |
Clinical significance of QT-prolonging drug use in patients with MDR-TB or NTM disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Azithromycin; Child; Clarithromycin; Clofazimine; Diarylquinolines; Female; Fluoroquinolones; Follow-Up Studies; Humans; Lost to Follow-Up; Macrolides; Male; Middle Aged; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nitroimidazoles; Nontuberculous Mycobacteria; Oxazoles; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult | 2017 |
Nodular skin lesion secondary to Mycobacterium abscessus tenosynovitis.
Topics: Aged; Clarithromycin; Clofazimine; Debridement; Female; Fingers; Humans; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Skin Diseases; Tenosynovitis | 2018 |
Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Buruli Ulcer; Clarithromycin; Clofazimine; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Electron Transport; Humans; Imidazoles; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium ulcerans; Piperidines; Pyridines; Rifampin; Streptomycin | 2019 |
Rare case of pacemaker infection with
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Arrhythmias, Cardiac; Cefoxitin; Clarithromycin; Clofazimine; Drug Resistance, Bacterial; Epidural Abscess; Heroin Dependence; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Pacemaker, Artificial; Prosthesis-Related Infections | 2019 |
In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Clofazimine; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin | 2022 |
Physiologically Based Pharmacokinetic Modeling To Guide Management of Drug Interactions between Elexacaftor-Tezacaftor-Ivacaftor and Antibiotics for the Treatment of Nontuberculous Mycobacteria.
Topics: Anti-Bacterial Agents; Benzodioxoles; Clarithromycin; Clofazimine; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Nontuberculous Mycobacteria; Pyrrolidines; Rifabutin | 2022 |
Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Clofazimine; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Thioridazine; Tigecycline; Verapamil | 2022 |
[In vitro Activity of Rifabutin and Clofazimine to Macrolide-Resistant Mycobacterium abscessus Complex Clinical Isolates].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Drug Resistance, Bacterial; Humans; Macrolides; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Rifabutin | 2023 |